Search results for: 'Preferred Destination for Early Phase Clinical Trials'

03 Feb 2021  |  North America  |  Market Research

Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

Infographics

×

2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...

This market insight focuses on the demand for different types of probiotics and enzymes in North America and Europe. The segments are split, based on the food applications. The price variations of probitoics and enzymes are provided, in addition to the market share of major participants. This market insight also covers the current competitive scena...

25 Mar 2022  |  North America  |  Frost Radar

Frost Radar™: North American Clinical Documentation Improvement Market, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facilita...

This study provide in-depth analysis on the North American market for three-phase uninterruptible power supplies (UPS). Market analysis also includes revenue forecast by power range and participation by end user markets. Also included in the study is discussion on the competitive structure, distribution channels, and market share analysis.

This growth opportunity-technology (GO-TE) study identifies and analyzes some of the key developments in diagnostic medical devices across major therapeutic areas such as cardiology, neurology, and oncology. The research highlights the breakthrough diagnostic medical device technologies that are likely to be approved in the next 2-3 years. These pr...

The mHealth enabled care market is growing at a rapid pace with over 0.15 million health apps in 2015 leading to an endless number of possibilities of smartphone usage for revolutionizing healthcare. From reading and analyzing a patient’s vital body data, medication adherence, and chronic disease management to early diagnosis of complex disorders w...

The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...

This research service analyzes the market for clinical laboratory analyzers within the United States. The United States market was divided into the clinical chemistry, immunoassay, integrated, hematology, hemostasis, and blood gas analyzer market segments. Each segment of this service covers market drivers, market restraints, competitive structur...

Medical devices utilizing single imaging technology have been used for decades. While single imaging technology has its merits, multimodal or combination of different imaging techniques have the potential to improve the diagnostic accuracy of the physician and help achieve better treatment outcomes. With the introduction of whole-body PET-CT and SP...